KKR Real Estate Finance Trust

KREF · NYSE

$5.64−$0.05 (−0.88%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $5.69

KREF analyst rating

HoldConsensus of 5 analysts over the last 12 months. 20% rate it a buy.

Strong buy0
Buy1
Hold3
Underperform1
Sell0

12-month price target · 7 analysts

Average $9.31 (+65.0% upside)

Low: $7.07
Now: $5.64
High: $13.65

Upgrades and downgrades

The latest rating actions, newest first

KREF analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Keefe, Bruyette & Woods	Oct 9, 2026	Maintains	Market Perform	$7.00 → $6.50	51%
JP Morgan	Jul 24, 2026	Maintains	Underweight	$8.00 → $7.50	56%
Keefe, Bruyette & Woods	Jul 23, 2026	Maintains	Market Perform	$6.50 → $7.00	51%
JP Morgan	Jul 17, 2026	Downgrade	Neutral → Underweight	$8.00	56%
Wells Fargo	Apr 28, 2026	Maintains	Overweight	$9.00 → $7.00	56%
Citizens	Apr 27, 2026	Downgrade	Market Outperform → Market Perform	—	26%
Keefe, Bruyette & Woods	Apr 24, 2026	Maintains	Market Perform	$7.00 → $6.00	51%
JP Morgan	Apr 16, 2026	Maintains	Neutral	$8.00 → $6.50	56%
Keefe, Bruyette & Woods	Apr 8, 2026	Maintains	Market Perform	$8.00 → $7.00	51%
Citizens	Mar 23, 2026	Maintains	Market Outperform	$10.00 → $9.50	26%

The case for and against

Updated Jul 21, 2026

Bull case

KKR Real Est Finance Tr is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. With a well-diversified portfolio of institutional-quality assets and a strong management team backed by KKR, the company is well-positioned to generate attractive risk-adjusted returns for its stockholders over the long term. While there are potential risks such as non-performing loans and potential dividend cuts, improvements in the loan book stability and potential growth opportunities in the CRE transaction market could boost investor sentiment and drive the company's earnings and stock performance in 2026.

Bear case

KKR Real Est Finance Tr is a publicly traded real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. However, recent concerns have arisen surrounding the company's leverage levels, life science loan exposure, and potential earnings disruption due to portfolio shifts. While KKR Real Est Finance Tr has a strong origination platform, asset management expertise, and strong borrower relationships, these concerns may lead to share price stagnation in the near-term. Additionally, KKR Real Est Finance Tr faces risks such as non-performing loan resolution, lower-than-expected originations, and challenges within the life science loan portfolio. As a result, it may be best to adopt a neutral rating on this stock given current market conditions and potential risks.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.